Royal Alexandra Hospital
Edmonton, Alberta, T5H 3V9, Canada
NCT Number: NCT01541839
The primary objective of this study is to determine if there is a time savings in the operating room by using a septal stapler instead of suture in closure of primary septoplasty.
The secondary objectives are to determine the subjective outcome of patients undergoing closure with the septal stapler instead of suture via questionnaire, and to determine if there is a difference in postoperative complications between groups.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Edmonton, Alberta, T5H 3V9, Canada
Nasal Septoplasty is the third most common surgical procedure performed by otolaryngologists. The surgery is done to relieve nasal obstruction, which is often caused by a bend in the tissues in the middle of the nose. The current technique for completing a septoplasty involves elevating subperichondrial flaps bilaterally and resecting the deviated portion of cartilage and/or bone. The technique to prevent a septal hematoma by removing the potential dead space after cartilage resection has evolved over time. Traditionally, the nose was packed with petroleum gauze, but using sutures to coapt the mucosa back together has become the preferred method of choice.
Placing sutures to reapproximate the mucosa is very effective, but can be challenging, particularly in a narrow nose. The amount of time required varies from 4 to 20 minutes for this part of the surgery, and is potentially associated with its own set of complications. The needle or suture can break, and the lateral nasal wall can be traumatized, leading to formation of scar bands to the septum.
Recently, a septal stapler has been developed that uses bioabsorbable staples. The staples are made of polylactide-co-glycolide (PLG), the same copolymer found in Vicryl sutures. It can provide a more uniform closure, is able to reach the posterior septum and could lead to a significant time savings in the operating room. The stapler has been demonstrated to be safe and effective, and required less than a minute to apply in most studied cases. The amount of time saved in the operating room has not yet been studied.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This device is a stapler designed to place resorbable implants into the nasal septum. Each device contains 8 staples.
Other names: ENTact Septal Stapler (ENTrigue surgical 601-00100)
Time frame: 1 day
The primary outomce of this study is to determine if time is saved in the operating room by using the septal stapler instead of suture.
Time frame: up to 2 months
The subjective outcome of patients undergoing closure with the septal stapler versus suture will be assessed via the Nasal Obstruction Symptom Evaluation (NOSE) questionnaire.
The NOSE questionnaire rates a patient's symptoms using a 0-4 scale where 0 is "Not a problem" and 4 is "Severe problem"
Time frame: 3 weeks
The number of post-operative complications (synechiae, septal perforation) assessed at three-week follow-up by a physician.
University of Alberta
Other
Randomized, Controlled Trial Comparing an Endoscopic Septal Stapler to Suture Closure in Primary Septoplasty
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06438185
Airway Obstruction, Inferior Turbinate Hypertrophy
Tel Aviv, Israel
View Trial DetailsNCT04150783
Airway Obstruction, Cleft Lip
Durham, North Carolina, United States
View Trial DetailsNCT05099263
Airway Obstruction, Nasal Obstruction
Colorado Springs, Colorado, United States
View Trial DetailsNCT07140250
Airway Obstruction, Infections
La Jolla, California, United States
View Trial Details